ABG Analytics logo
 

Merck & Co (NYSE: MRK)

DRUGS - Drug Manufacturers - Major
Sector: Health Care
Stock price data as of 02/07/2025
Closing price: 87.28
Support price level: N/A
Resistance price level: $96.01
Relative strength index (14-day RSI) 26.1
Beta 0.01
  • MRK is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.

  • With a -31.2 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.

  • MRK is one of this month's worst performers with a return of -12.6%, underperforming 90 percent of stocks in the S&P-100.

  • Down 11.7 percent, MRK is one of this week's biggest decliners.

  • The price of this low-beta stock is expected to increase by 0.01% for every 1% increase in the S&P-500.

  • Volatility is forecast to fall over the next month.

  • With RSI < 30, MRK is oversold. Odds slightly favor a short-term price reversal.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$87.28 $132.96 0.0%
200 day 50 day 20 day 10 day
$113.56 $98.93 $96.48 $94.70
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
23.8% 20.5% 38.0% 29.5%
There is an estimated 5% probability that the stock price of Merck & Co will fall by more than:
  • 10.3% in the next week.

  • 16.7% in the next month.

  • 44.7% in the next year.